Pierre-Régis Burgel

75PUBLICATIONS
183CO-AUTHORS
Data and information privacyDisease surveillanceFluid-structure interaction and aeroacousticsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Sep 08, 2026
Mental health safety profile of CFTR modulators in pediatrics and adults: insights from the French pharmacovigilance database and from VigiBase.

|Sep 02, 2026
SOLAR: a noninterventional study of outcomes over the long term of people with cystic fibrosis (CF) aged ≥6 years treated with elexacaftor/tezacaftor/ivacaftor using data from the French CF Registry.

|Aug 18, 2026
Persistence of static lung hyperinflation in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.

|Jul 31, 2026
CFTR modulators exert subset-specific phenotype remodeling on circulating neutrophils in cystic fibrosis.

|Jul 14, 2026
The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

|Jan 22, 2026
Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric study.

Charlène Lefèvre, Théo Funck-Brentano, Marine Cachanado

Pageof 13

Frequent Collaborators

15 joint publications

Clémence Martin

7 joint publications

Stefano Aliberti

7 joint publications

Michal Shteinberg

6 joint publications

Felix C Ringshausen